- Journal Archives
- Volume 16
- Volume 15
- Volume 14
- Volume 13
- Volume 12
- Volume 11
- Volume 10
- Volume 9
- Volume 8
- Volume 7
- Volume 6
- Volume 5
- Volume 4
- Volume 3
- Volume 2
- Volume 1
Currently viewing the tag: "FDA"
The Supreme Court grants cert in the Aereo case, which pits the over-the-air TV streaming upstart against the big broadcasting [...]Continue Reading →
In the news . . .
Google and NSA team up to fight cyberattacks.
Scientists discover energy teleportation.
Seventh Circuit upholds prison ban on Dungeons & Dragons against First and Fourteenth Amendment challenge.Continue Reading →
In the news . . .
Wired writer tries to find out if it’s possible to disappear in the digital world.
England’s proposed new copyright laws are extremely controversial.
Insurance company takes away Canadian woman’s long-term sick leave benefit after Facebook photos indicate she wasn’t suffering from depression.
Sony [...]Continue Reading →
On November 12, 2009 By Brian Van Wyk July 24, 2010
In September 2009, the FDA adopted a new regulation banning flavored tobacco. The ban specifically targets candy and fruit-flavored cigarettes. While this issue may be obscure to some, for others, it’s a big deal–their favorite brands of cigarettes have been made illegal with little public debate while the country is occupied with a tanking economy [...]Continue Reading →
Pfizer offered a major “mea culpa” last week when it agreed to pay $2.3 billion in fines for the “largest combined federal and state health care fraud settlement in the history of the Department of Justice.” The pharmaceutical company has ended up in this less than esteemed position as a result of its [...]Continue Reading →
Most people agree that a generic biologics pathway for the U.S. Food and Drug Administration (FDA) approval of these drugs would be a boon to consumers, but different parties seem to be at odds on the exact exclusivity period that the pharmaceutical companies should be given from their generic drug competitors.
These generic biologics [...]Continue Reading →
Over the Counter but Under the Radar: Direct-to-Consumer Genetic Tests and FDA Regulation of Medical Devices
On May 6, 2009 By JETLaw May 6, 2009
Look for Over the Counter but Under the Radar: Direct-to-Consumer Genetic Tests and FDA Regulation of Medical Devices in the Spring 2009 issue (Vol. 11, No. 3) of the Vanderbilt Journal of Entertainment and Technology Law. The Abstract for the Note follows:
Direct-to-consumer genetic tests are laboratory-developed tests that are marketed and sold directly to consumers. [...]Continue Reading →
Coca-Cola has received a warning letter from the FDA informing the company that its beverage, Diet Coke Plus, does not meet FDA criteria to warrant the designation of “plus,” and is thus in violation of section 403(r)(1)(A) of the Food, Drug, and Cosmetic Act.
The term “plus,” as well as the [...]Continue Reading →
Recent Blog Posts
- $400 Million Settlement: E-book Price-Fixing May Cost Apple Big Time
- Kramer Sues Seinfeld Staff Writer for Defamation–and Loses
- Which “Duke” Will Reign?: Wayne Estate Seeks to Limit the Reach of Trademarks
- The Miss America Rule
- Possible Changes Coming to E-Discovery Rules
- “What Would Jesus Do” Trademark Win for Tyler Perry
Tagsadvertising antitrust Apple books career celebrities contracts copyright copyright infringement courts creative content criminal law entertainment Facebook FCC film/television financial First Amendment games Google government intellectual property internet JETLaw journalism lawsuits legislation media medicine Monday Morning JETLawg music NFL patents privacy progress publicity rights radio social networking sports Supreme Court of the United States (SCOTUS) technology telecommunications trademarks Twitter U.S. Constitution